Can-Fite BioPharma (CANF) – Downgrades
-
Maxim Group Downgrades Can-Fite BioPharma (CANF) to Hold Citing Dilutive Capital Raise
-
UPDATE: Can-Fite BioPharma's (CANF) CF101 Phase 2/3 Missed Primary Endpoint; Roth Downgrades to Neutral
Back to CANF Stock Lookup